Dowling & Yahnke’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Dowling & Yahnke’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.75M	Hold
2022 Q2	$836K	Buy
2022 Q1	$902K	Hold
2021 Q4	$944K	Buy